These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35709482)

  • 21. Optimized labeling of NOTA-conjugated octreotide with F-18.
    Laverman P; D'Souza CA; Eek A; McBride WJ; Sharkey RM; Oyen WJ; Goldenberg DM; Boerman OC
    Tumour Biol; 2012 Apr; 33(2):427-34. PubMed ID: 22009690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation.
    Selvaraj R; Giglio B; Liu S; Wang H; Wang M; Yuan H; Chintala SR; Yap LP; Conti PS; Fox JM; Li Z
    Bioconjug Chem; 2015 Mar; 26(3):435-42. PubMed ID: 25679331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imidazolium-methylene-trifluoroborate: A novel radioprosthetic group validated with preclinical
    Lozada J; Kuo HT; Lin WX; Lin KS; Bénard F; Perrin DM
    J Labelled Comp Radiopharm; 2023; 66(4-6):130-137. PubMed ID: 36813569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
    Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
    Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma Imaging Using
    Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
    Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
    Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
    Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An [
    Guo H; Kommidi H; Maachani UB; Voronina JC; Zhang W; Magge RS; Ivanidze J; Wu AP; Souweidane MM; Aras O; Ting R
    Mol Pharm; 2019 Aug; 16(8):3636-3646. PubMed ID: 31290330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET.
    Leyton J; Iddon L; Perumal M; Indrevoll B; Glaser M; Robins E; George AJ; Cuthbertson A; Luthra SK; Aboagye EO
    J Nucl Med; 2011 Sep; 52(9):1441-8. PubMed ID: 21852355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.
    Poethko T; Schottelius M; Thumshirn G; Hersel U; Herz M; Henriksen G; Kessler H; Schwaiger M; Wester HJ
    J Nucl Med; 2004 May; 45(5):892-902. PubMed ID: 15136641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and ex vivo biodistribution of two
    Lambidis E; Lumén D; Koskipahta E; Imlimthan S; Lopez BB; Sánchez AIF; Sarparanta M; Cheng RH; Airaksinen AJ
    Nucl Med Biol; 2022; 114-115():151-161. PubMed ID: 35680503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosynthesis and Preclinical Evaluation of
    Maschauer S; Heilmann M; Wängler C; Schirrmacher R; Prante O
    Bioconjug Chem; 2016 Nov; 27(11):2707-2714. PubMed ID: 27715017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.
    Litau S; Niedermoser S; Vogler N; Roscher M; Schirrmacher R; Fricker G; Wängler B; Wängler C
    Bioconjug Chem; 2015 Dec; 26(12):2350-9. PubMed ID: 26420336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.
    Kwan KH; Burvenich IJG; Centenera MM; Goh YW; Rigopoulos A; Dehairs J; Swinnen JV; Raj GV; Hoy AJ; Butler LM; Scott AM; White JM; Ackermann U
    Nucl Med Biol; 2021 Feb; 93():37-45. PubMed ID: 33310350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
    Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
    Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformationally Strained trans-Cyclooctene (sTCO) Enables the Rapid Construction of (18)F-PET Probes via Tetrazine Ligation.
    Wang M; Svatunek D; Rohlfing K; Liu Y; Wang H; Giglio B; Yuan H; Wu Z; Li Z; Fox J
    Theranostics; 2016; 6(6):887-95. PubMed ID: 27162558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
    Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
    Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
    [No Abstract]   [Full Text] [Related]  

  • 38. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
    Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
    Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of Structurally Diverse
    Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
    ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of
    Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S
    Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.